BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,486,000 | -36.2% | 1,500,000 | -35.3% | 1.26% | -14.5% |
| Q1 2022 | $2,330,000 | -4.6% | 2,320,000 | 0.0% | 1.47% | -7.8% |
| Q4 2021 | $2,442,000 | +2.0% | 2,320,000 | 0.0% | 1.59% | +11.6% |
| Q3 2021 | $2,395,000 | -18.5% | 2,320,000 | -17.7% | 1.43% | +6.7% |
| Q2 2021 | $2,938,000 | +1.5% | 2,820,000 | 0.0% | 1.34% | -27.1% |
| Q1 2021 | $2,895,000 | -16.1% | 2,820,000 | -12.4% | 1.84% | +5.1% |
| Q4 2020 | $3,452,000 | +2.5% | 3,220,000 | 0.0% | 1.75% | +5.0% |
| Q3 2020 | $3,368,000 | +10.8% | 3,220,000 | +30.4% | 1.66% | -19.0% |
| Q2 2020 | $3,040,000 | +18.0% | 2,470,000 | 0.0% | 2.05% | -22.6% |
| Q1 2020 | $2,576,000 | -24.6% | 2,470,000 | -23.3% | 2.65% | +28.2% |
| Q4 2019 | $3,416,000 | +7.6% | 3,220,000 | 0.0% | 2.07% | +3.3% |
| Q3 2019 | $3,176,000 | +19.6% | 3,220,000 | +26.3% | 2.00% | +4.0% |
| Q2 2019 | $2,656,000 | +1.1% | 2,550,000 | 0.0% | 1.93% | -21.5% |
| Q1 2019 | $2,626,000 | -12.1% | 2,550,000 | -15.0% | 2.46% | -13.0% |
| Q4 2018 | $2,986,000 | -6.1% | 3,000,000 | 0.0% | 2.82% | +49.4% |
| Q3 2018 | $3,179,000 | +4.2% | 3,000,000 | 0.0% | 1.89% | -13.1% |
| Q2 2018 | $3,050,000 | – | 3,000,000 | – | 2.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,732,000 | $16,408,385 | 1.23% |
| SONA ASSET MANAGEMENT (US) LLC | 23,125,000 | $22,451,923 | 0.93% |
| SSI INVESTMENT MANAGEMENT LLC | 8,726,000 | $8,464,220 | 0.69% |
| PFM Health Sciences, LP | 15,000,000 | $14,587,500 | 0.69% |
| RWC Asset Management LLP | 10,000,000 | $9,709,000 | 0.63% |
| Sonora Investment Management Group, LLC | 6,245,000 | $6,108,182 | 0.52% |
| Paloma Partners Management Co | 10,006,000 | $9,733,285 | 0.34% |
| MACKAY SHIELDS LLC | 9,891,000 | $9,594,270 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 8,704,000 | $8,455,066 | 0.24% |
| Centiva Capital, LP | 10,000,000 | $9,716,288 | 0.21% |